Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$608,175.00
Apr 1, 2017
Identifying genes and regulatory pathways that control sex differences in lipid storage using Drosophila as a model.
$673,200.00
Apr 1, 2017
Novel therapy for Hyperkalemic Periodic Paralysis (HyperKPP)
$573,750.00
Apr 1, 2017
Small nucleolar RNAs as regulators of gene expression
$971,552.00
Apr 1, 2017
Advancing Mental Health Care by Improving the Delivery of Therapist-guided, Internet-delivered Cognitive Behavioural Therapy in Clinical Practice
$642,600.00
Apr 1, 2017
CD200 dysregulation in asthma: potential for therapy?
$135,000.00
Apr 1, 2017
Oncolytic rhabdovirus vaccines as an adjuvant to adoptive T cell therapy for paediatric metastatic rhabdomyosarcomas: Precision targeting, expansion and trafficking
$765,000.00
Apr 1, 2017
Therapy development for myotubular myopathy and related disorders
$100,000.00
Apr 1, 2017
Roles of retrotransposon silencing in genome instability and cancer therapy
$822,375.00
Apr 1, 2017
Role of Gene Expression Changes in the Mechanism of Action of Long-acting Beta2-adrenoceptor Agonists in COPD
$229,500.00
Apr 1, 2017
The Emerging Field of Cardiovascular-Oncology: Role of Tumor Suppressor Breast Cancer Susceptibility Gene 2 (BRCA2) in Endothelial Dysfunction and Atherosclerosis